Szałek E - Search Results

1

The use of Ctrough for the therapeutic drug monitoring of olaparib in patients with ovarian cancer.

Stanisławiak-Rudowicz J, Szałek E, Grzebalska M, Urjasz H, Michalak M, Mądry R, Grześkowiak E. Stanisławiak-Rudowicz J, et al. Among authors: szalek e. Eur Rev Med Pharmacol Sci. 2022 Dec;26(24):9426-9436. doi: 10.26355/eurrev_202212_30694. Eur Rev Med Pharmacol Sci. 2022. PMID: 36591851 Free article.

2

Pharmaceutical availability of clobetasol-17-propionate from cream and ointment.

Dyderski S, Grześkowiak E, Szałek E, Mrzygłód A. Dyderski S, et al. Among authors: szalek e. Acta Pol Pharm. 2001 Nov-Dec;58(6):435-8. Acta Pol Pharm. 2001. PMID: 12197615 Free article.

3

Pharmaceutical availability of betamethasone dipropionate and gentamicin sulfate from cream and ointment.

Dyderski S, Grześkowiak E, Szałek E, Mrzygłód A. Dyderski S, et al. Among authors: szalek e. Acta Pol Pharm. 2002 Mar-Apr;59(2):99-103. Acta Pol Pharm. 2002. PMID: 12365612 Free article.

4

Bioavailability study of drotaverine from capsule and tablet preparations in healthy volunteers.

Dyderski S, Grześkowiak E, Drobnik L, Szałek E, Balcerkiewicz M, Dubai V. Dyderski S, et al. Among authors: szalek e. Arzneimittelforschung. 2004;54(5):298-302. doi: 10.1055/s-0031-1296974. Arzneimittelforschung. 2004. PMID: 15212193 Clinical Trial.

5

Comparative bioavailability study of two preparations of letrozole in healthy subjects.

Dyderski S, Grześkowiak E, Szałek E, Szkutnik D, Dubai V, Drobnik L. Dyderski S, et al. Among authors: szalek e. Arzneimittelforschung. 2005;55(9):514-9. doi: 10.1055/s-0031-1296898. Arzneimittelforschung. 2005. PMID: 16229115

6

Bioequivalence study of two losartan formulations administered orally in healthy male volunteers.

Bienert A, Brzezińiski R, Szałek E, Dubai V, Grześkowiak E, Dyderski S, Drobnik L, Wolc A, Olejniczak-Rabinek M. Bienert A, et al. Among authors: szalek e. Arzneimittelforschung. 2006;56(11):723-8. doi: 10.1055/s-0031-1296781. Arzneimittelforschung. 2006. PMID: 17220048 Clinical Trial.

7

The PK/PD index (CMAX/MIC) for ciprofloxacin in patients with cystic fibrosis.

Szałek E, Kamińska A, Gozdzik-Spychalska J, Grześkowiak E, Batura-Gabryel H. Szałek E, et al. Acta Pol Pharm. 2011 Sep-Oct;68(5):777-83. Acta Pol Pharm. 2011. PMID: 21928725 Free article.

8

Comparison of the pharmacokinetics of paracetamol from two generic products in patients after total gastric resection.

Szałek E, Kamińska A, Murawa D, Połom K, Urbaniak B, Sobiech M, Grześkowiak E, Grabowski T, Wolc A, Kokot ZJ, Murawa P. Szałek E, et al. Pharmacol Rep. 2011;63(6):1518-25. doi: 10.1016/s1734-1140(11)70715-0. Pharmacol Rep. 2011. PMID: 22358099 Free article.

9

Effect of total and partial nephrectomy on the elimination of ciprofloxacin in humans.

Szałek E, Połom W, Karbownik A, Grabowski T, Konkołowicz A, Wolc A, Matuszewski M, Krajka K, Grześkowiak E. Szałek E, et al. Pharmacol Rep. 2012;64(3):673-9. doi: 10.1016/s1734-1140(12)70862-9. Pharmacol Rep. 2012. PMID: 22814020 Free article.

10

[Optimization of antibiotic therapy in pregnancy--clinical implications].

Szałek E, Tomczak H, Seremak-Mrozikiewicz A, Bartkowiak-Wieczorek J, Grześkowiak E. Szałek E, et al. Ginekol Pol. 2012 Jun;83(6):462-8. Ginekol Pol. 2012. PMID: 22880468 Review. Polish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters